Science. Simplicity. Partnership.

 

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
Respiratory

Four-plex test for SARS-CoV-2, Influenza A/B and RSV receives FDA Emergency Use Authorization

Now, HCPs will be able to detect and differentiate these respiratory viruses within a single patient visit, enabling improved public health outcomes.

Latest news

 

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) — a key marker for hereditary cardiovascular risk
Cardiometabolic
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a)

We're paving the way to make elevated Lp(a) an actionable biomarker for hereditary cardiovascular risk.

Learn more

Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer
Cervical Cancer
Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S.

We're expanding access and screening options to help eliminate cervical cancer.

Learn more

Roche subsidiary GenMark Diagnostics introduces the rebranded and improved cobas® eplex system
Multiplex testing
Introducing the rebranded and improved cobas® eplex system

Roche and GenMark are dedicated to providing world-class solutions for multiplex testing.

Learn more

Related links

Products

Learn more about our portfolio of lab instruments, systems, assays and more  

Begin exploring

Documents

More than 800,000 documents available on demand — always up-to-date with 24/7 access

Log in to eLabDoc

Education

Empowering learning — e-learning content, PACE/CEU courses, and more

Start training